Bisphenol A Causes Hyperactivity in the Rat Concomitantly with Impairment of Tyrosine Hydroxylase Immunoreactivity

Journal of Neuroscience Research

Volumn 76, Issue 3, 2004, Pages 423-433

  Ishido, Masami ^a   Masuo, Yoshinori ^b   Kunimoto, Manabu ^c   Oka, Syuichi ^b   Morita, Masatoshi ^a  

^a NATIONAL INSTITUTE FOR ENVIRONMENTAL STUDIES   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^c KITASATO UNIVERSITY   (Japan)

Author keywords

Bisphenol A; DNA array; Endocrine disruptors; Hyperactivity; Tyrosine hydroxylase

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; DNA; DOPAMINE 4 RECEPTOR; DOPAMINE TRANSPORTER; TYROSINE 3 MONOOXYGENASE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DETERMINATION; DOPAMINERGIC SYSTEM; DOPAMINERGIC TRANSMISSION; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; HYPERACTIVITY; IMMUNOREACTIVITY; MALE; MESENCEPHALON; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; UNINDEXED SEQUENCE;

AGE FACTORS; ANIMALS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGENS, NON-STEROIDAL; FEMALE; HYPERKINESIS; INJECTIONS, INTRAVENTRICULAR; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; NERVE TISSUE PROTEINS; PHENOLS; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SUBARACHNOID SPACE; TYROSINE 3-MONOOXYGENASE;

EID: 2342486075     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.20050     Document Type: Article

References (59)

1. Ashby J, Tinwell H. 2000. Uterotrophic activity of bisphenol A in the immature rat. Environ Health Perspect 106:719-720.
2. Atkinson A, Roy D. 1995. In vitro conversion of environmental estrogenic chemical bisphenol A to DNA binding metabolite(s). Biochem Biophys Res Commun 210:424-433.
3. Behl C. 2002. Oestrogen as a neuroprotective hormone. Nat Rev Neurosci 3:433-442.
4. Ben-Jonathan N, Steinmetz R. 1998. Xenoestrogens: the emerging story of bisphenol A. Trend Endocrinol Metab 9:124-128.
5. Beresford N, Routledge EL, Hariss CA, Sumpter JP. 2000. Issues arising when interpreting results from an in vitro assay for estrogenic activity. Toxicol Appl Pharmacol 162:22-33.
6. Bergeron RM, Thompson TB, Leonard LS, Pluta L, Gaido KW. 1999. Estrogenicity of bisphenol A in a human endometrial carcinoma cell line. Mol Cell Endocrinol 150:179-187.
7. Borges CR, Geddes T, Watson JT, Kuhn DM. 2002. Dopamine biosynthesis is regulated by S-glutathionylation. Potential mechanism of tyrosine hydroxylast inhibition during oxidative stress. J Biol Chem 277:48295-48302.
8. Brotons JA, Serrano FO, Villalobos M, Pedraza V, Olea N. 1995. Xenoestrogens released from lacquer coatings in food cans. Environ Health Perspect 103:608-612.
9. Crabbe JC, Phillips TJ, Feller DJ, Hen R, Wenger CD, Lessov CN, Schafer GL. 1996. Elevated alcohol consumption in null mutant mice lacking 5-HT1B serotonin receptors. Nat Genet 14:98-101.
10. Crawley JN. 2000. What's wrong with my mouse? Behavioral phenotyping of transgenic and knockout mice. New York: Wiley-Liss.
11. Chen C, Rainnie DG, Greene RW, Tonegawa S. 1994. Abnormal fear response and aggressive behavior in mutant mice deficient for alpha-calcium-calmodulin kinase II. Science 266:291-294.
12. Dluzen D. 1997. Estrogen decreases corpus striatal neurotoxicity in response to 6-hydroxydopamine. Brain Res 767:340-344.
13. Elia J, Ambrosini PJ, Rapoport J. 1999. Treatment of attention-deficit-hyperactivity disorder. N Engl J Med 340:780-788.
14. Frith U. 2002. Mind blindness and the brain in autism. Neuron 32:969-979.
15. Gainetdinov RG, Wetsel WC, Jones SR, Levin ED, Jaber M, Caron MG. 1999. Role of serotonin in the paradoxical calming effects of psychostimulants on hyperactivity. Science 283:397-401.
16. Gerber D, Somikova TD, Gainetdinov RR, Huang SY, Caron M, Tonegawa S. 2001. Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci USA 98:15312-15317.
17. Gillberg C, Wing L. 1999. Autism: not an extremely rare disorder. Acta Psychiatr Scand 99:399-406.
18. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG. 1996. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606-612.
19. Goldman LS, Genel M, Bezman RJ, Slanetz PJ. 1998. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents. JAMA 279:1100-1107.
20. Hara J, Beuckman CT, Nambu T, Willie JT, Chemelli RM, Sinton CM, Sugiyama F, Yagami K, Goto K, Yanagisawa M, Sakurai T. 2001. Genetic ablation of orexin neurons in mice results in narcolepsy, hyperphagia, and obesity. Neuron 30:345-354.
21. Hsu SM, Raine L. 1981. Protein A, avidin, and biotin in immunohistochemistry. J Histochem Cytochem 29:1309-1351.
22. Ishido M, Nitta H, Kabuto M. 2001. Magnetic fields (MF) of 50 Hz and 1.2 μT as well as 100 μT cause uncoupling of inhibitory pathways of adenylyl cyclase mediated by melatonin 1a receptor in MF-sensitive MCF-7 cells. Carcinogenesis 22:1043-1048.
23. Ishido M, Masuo Y, Oka S, Kunimoto M, Morita M. 2002a. Application of Supermex system to screen behavioral traits produced by tributyltin in the rat. J Health Sci 48:451-454.
24. Ishido M, Ohtsubo R, Adachi T, Kunimoto M. 2002b. Attenuation of both apoptotic and necrotic actions of cadmium by Bcl-2. Environ Health Perspect 110:37-42.
25. Jacobson JL, Jacobson SW. 1996. Intellectual impairment in children exposed to polychlorinated bisphenyls in utero. N Engl J Med 335:783-789.
26. Jacobson M. 1991. Developmental neurobiology. New York: Plenum Press.
27. Jiang M, Gold MS, Boulay G, Spicher K, Peyton M, Brabet P, Srinivasan Y, Rudolph U, Ellison G, Bimbaumer L. 1998. Multiple neurological abnormalities in mice deficient in the G protein Go. Proc Natl Acad Sci USA 95:3269-3274.
28. Kamimura E, Ueno Y, Tanaka S, Sawa H, Yoshioka M, Ueno K, Inoue T, Li X, Koyama T, Ishikawa R, Nagashima K. 2001. New rat model for attention deficit hyperactive disorder (ADHD). Comparative Med 51: 245-251.
29. Kawai K, Nozaki T, Nishikata H, Aou S, Takii M, Kubo C. 2003. Aggressive behavior and serum testosterone concentration during the maturation process of male mice: the effects of fetal exposure to bisphenol A. J Health Perspect 111:175-178.
30. Krishman AV, Stathis P, Permuth SF, Tokes L, Feldman D. 1993. Bisphenol A: An estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132:2279-2286.
31. Kubo K, Arai O, Ogata R, Omura M, Hori T, Aou S. 2001. Exposure to bisphenol A during the fetal and suckling periods disrupts sexual differentiation of the locus coeruleus and of behavior in the rat. Neurosci Lett 304:73-76.
32. Kuhn DM, Arthur RE Jr, Thomas DM, Elferink LA. 1999. Tyrosine hydroxylase is inactivated by catechol-quinones and converted to a redoxcycling quinoprotein: possible relevance to Parkinson's disease. J Neurochem 73:1309-1317.
33. Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson JA. 1997. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 138:863-870.
34. Kunimoto M, Adachi T, Ishido M. 1998. Expression and localization of brain ankyrin isoforms and related proteins during early developmental stages of rat nervous system. J Neurochem 71:2585-2592.
35. LaHoste GJ, Swanson JM, Wigal SB, Galbe C, Wigal T, King N, Kennedy J. 1996. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1:121-124.
36. Laws SC, Carey SA, Ferrell JM, Bodman GJ, Cooper RL. 2000. Estrogenic activity of octylphenol, nonylphenol, bisphenol and methoxychlor in rats. Toxicol Sci 54:154-167.
37. London F, Etzel RA. 2000. The environment as an etiologic factor in autism: a new direction for research. Environ Health Perspect 108(Suppl): 401-404.
38. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, Reid SW, Bora SH, Wihler C, Koliatsos VE, Tessarollo L. 1999. Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci USA 96:15239-15244.
39. Masuo Y, Noguchi J, Morita S, Matsumoto Y. 1995. Effects of intracerebroventricular administration of pituitary adenylate cyclase-activating polypeptide (PACAP) on the motor activity and reserpine-induced hypothermia in murines. Brain Res 700:219-226.
40. Masuo Y, Matsumoto Y, Morita S, Noguchi J. 1997. A novel method for counting spontaneous motor activity in the rat. Brain Res Brain Res Protoc 1:321-326.
41. Miyakawa T, Yamada M, Duttaroy A, Wess J. 2001. Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21:5239-5250.
42. Miyakoda H, Tabata M, Onodera S, Takeda K. 1999. Passage of bisphenol A into the fetus of the pregnant rat. J Health Sci 45:318-323.
43. Mori C. 2001. Assessment of fetal environmental exposure and subtle male reproductive disorders in Japan. Proceedings of the 1st U.S.-Japan workshop on endocrine disrupting chemicals and their toxicological evaluation. p 103-106.
44. Olea N, Pulgar R, Perez P, Serrano FO, Rivas A, Fertrell AN, Pedraza V, Soto AM, Sonnenschein C. 1996. Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 104:298-305.
45. Papaconstantinou AD, Umbreit TH, Fisher BR, Goering PL, Lappas NT, Brown KM. 2000. Bisphenol A-induced increase in uterine weight and alterations in uterine morphology in ovariectomized B6C3F1 mice: role of the estrogen receptor. Toxicol Sci 56:332-339.
46. Parks CL, Robinson PS, Sibille E, Shenk T, Toth M. 1998. Increased anxiety of mice lacking the serotonin1A receptor. Proc Natl Acad USA 95:10734-10739.
47. Patandin S, Lanting CI, Mulder PG, Boersma ER, Sauer PJ, Weisglas-Kuperus N. 1999. Effects of environmental exposure to polychlorinated biphenyls and dioxins on cognitive abilities in Dutch children at 42 months of age. J Pediatr 134:33-41.
48. Perez P, Pulgar R, Olea-Serrano F, Villalobos M, Rivas A, Metzler M, Pedraza V, Olea N. 1998. The estrogenicity of bisphenol A-related diphenylalkanes with various substituents at the central carbon and the hydroxy groups. Environ Health Perspect 106:167-174.
49. Rice DC. 2000. Parallels between attention deficit hyperactivity disorder and behavioral deficits produced by neurotoxic exposure in monkeys. Environ Health Perspect 108(Suppl):405-408.
50. Rice DC, Barone S Jr. 2000. Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ Health Perspect 108(Suppl):511-533.
51. Rubinstein M, Phillips TJ, Bunzow JR, Falzone TL, Dziewczapolski G, Zhang G, Fang Y, Larson JL, McDougall JA, Chester JA, Saez C, Pugsley TA, Gershanik O, Low MJ, Grandy DK. 1997. Mice lacking dopamine D4 receptors are supersensitive to ethanol, cocaine, and methamphetamine. Cell 90:991-1001.
52. Shaywitz BA, Yager RD, Klopper JH. 1976. Selective brain dopamine depletion in developing rats: an experimental model of minimal brain dysfunction. Science 191:305-308.
53. Stein DG. 2001. Brain damage, sex hormones and recovery: a new role for progesterone and estrogen? Trends Neurosci 24:386-391.
54. Steinmetz R, Brown NG, Allen DL, Bigsby RM, Ben-Jonathan N. 1997. The environmental estrogen bisphenol A stimulates prolactin release in vitro and in vivo. Endocrinology 138:1780-1786.
55. Steinmetz R, Mitchner NA, Grant A, Allen DL, Bigsby RM, Ben-Jonathan N. 1998. The xenoestrogen bisphenol A induces growth, differentiation, and c-fos gene expression in the female reproductive tract. Endocrinology 139:2741-2727.
56. Takai Y, Tsutsumi O, Ikezuki Y, Hiroi H, Osuga Y, Momoeda M, Yano T, Taketani Y. 2000. Estrogen receptor mediated effects of a xenoestrogen, bisphenol A, on preimplantation mouse embryos. Biochem Biophys Res Commun 270:918-921.
57. Uchida K, Suzuki A, Kobayashi Y, Buchanan DL, Sato T, Watanabe H, Katsu Y, Suzuki J, Asaoka K, Mori C, Arizono K, Iguchi T. 2002. Bisphenol A administration during pregnancy results in fetal exposure in mice and monkeys. J Health Sci 48:579-582.
58. Vorhees CV. 1986. Principles of behavioral teratology. In: Riley EP, Vorhees CV, editors. Handbook of behavioral teratology. New York: Plenum Press. p 23-48.
59. Xu M, Koeltzow TE, Santiago GT, Moratalla R, Cooper DC, Hu XT, White NM, Graybeil AM, White FJ, Tonegawa S. 1997. Dopamine D3 receptor mutant mice exhibit increased behavioral sensitivity to concurrent stimulation of D1 and D2 receptors. Neuron 19:837-848.